CA
NZ
UK
AU
IND
US
Avalyn Pharma (NASDAQ:AVLN) shares are trading down 5.39% to $25.68 after the lock-up period following its April IPO expired. The lock-up covered roughly 25.2 million common shares, plus stock options and warrants, held by directors, executive officers and holders of substantially all outstanding stock. …
Butterfly Network (NYSE:BFLY) shares are trading up 10.14% to $7.34 as investors position ahead of its third-quarter earnings report, due before the market opens on Thursday. The company also announced it will present at the UBS Global Healthcare Conference on November 10. No new …
Ginkgo Bioworks (NYSE:DNA) shares are trading up 11.33% to $11.16 after a report that a subsidiary of Agenus (NASDAQ:AGEN) signed a collaboration agreement with the company. The report gave no deal terms, so the details and financial impact are unclear. Shares opened at $10.12, …
HCA Healthcare (NYSE:HCA) shares are trading down 4.03% to $446.50 after the hospital operator reported third-quarter results that beat estimates but carried a clear payer mix cost. Adjusted EPS of $7.22 compared with roughly $6.65 expected, and revenue of $19.849 billion topped expectations near …
ImmunityBio (NASDAQ:IBRX) shares are trading up 9.50% to $8.55, rebounding from a four-session losing streak that ended with Monday's close at $7.81. A television market commentator described the stock as a promising speculative play and pointed to a wave of biotech takeovers, which renewed …
Inhibrx Biosciences (NASDAQ:INBX) shares are trading up 9.29% to $96.84, rebounding after slipping below the 200-day moving average of about $91.47 on Monday, when the stock closed near $88.61. The stock is now back above that level and near its 50-day average of $103.80. …
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) shares are trading up 22.98% to $89.75 after a third-quarter report that beat expectations on revenue and earnings. ARCALYST revenue rose about 58% from a year earlier to $286.0 million, ahead of an estimate near $260.7 million. Adjusted EPS of …
Lycia Therapeutics (NASDAQ:LYCA) shares are trading down 6.03% to $27.11 as investors digest the closing of its upsized initial public offering. The company sold 20,286,000 shares at $18.00 each, including the full exercise of the underwriters' option to buy 2,646,000 additional shares, for gross …
Rapport Therapeutics (NASDAQ:RAPP) shares are trading up 9.28% to $27.68 as investors continue to digest positive Phase 2 data for RAP-219 in bipolar mania. The trial met its primary and secondary endpoints, and the company plans to meet the FDA in the first quarter …
Twist Bioscience (NASDAQ:TWST) shares are trading up 10.50% to $160.50 as investors revisit the company's AI-driven drug discovery story ahead of fiscal fourth-quarter results. A small-cap growth investor letter highlighted better-than-expected revenue growth, a raised full-year outlook and rapid growth in AI-related orders, including …
Please wait processing your request...